The Institute for Bioengineering and Biosciences (iBB), through the Stem Cell Engineering Research Group (SCERG), participates in the project “PRECISE – Accelerating progress toward the new era of Precision Medicine”, recently approved, with a budget of 2.5 millions of Euros from “Programa Operacional Regional de Lisboa” and “Fundação para a Ciência e a Tecnologia”. This project started in December 2016 for three years.
PRECISE aims to accelerate progress of Portuguese health care toward the new era of precision medicine. It involves 3 institutions focusing on Medicine (iMM), Bioprocess and Stem Cell Engineering (iBB), and Information Systems (INESC-ID).Specifically, it will further develop knowledge, instruments and processes to accelerate innovation in technologies for health. It will deliver the prototype of a virtual research platform for Precision Medicine; better clinical decision-making for common immune-mediated diseases; improved diagnosis and treatment of rare immune-mediated diseases; new tools to genotype cancer; more accurate evaluation of molecular pathways altered in cancer; proof-of-principle for novel predictive tools for cancer; improvement in predictive prevention and personalized interventional stroke therapy; better understanding of mitochondrial diseases; improvement in predictive disease modelling; novel processes and best-practices for cell-based innovative medicinal products; improved education on state-of-the-art concepts in precision medicine; and new business ideas for products and services in the field of health and health care.